| 1 |
Beckhoff A, Steffen I, Sandoz P, et al. Relapsing severe anaemia due to primary parvovirus B19 infection after renal transplantation: A case report and review of the literature [J]. Nephrol Dial Transplant, 2007, 22(12): 3660-2663。
|
| 2 |
Kooistra K, Mesman HJ, Waal M, et al. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009 [J]. Vox Sang, 2011, 100(3): 261-266.
|
| 3 |
李帅阳, 沈兵, 刘志宏, 等. 肾移植术后人微小病毒B19感染导致纯红细胞增生障碍性贫血 [J]. 现代生物医学进展, 2012, 12(14): 2698-2702.
|
| 4 |
Macdougall IC, Casadevall N, Locatelli F, et al. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS) [J]. Nephrol Dial Transplant, 2015, 30(3): 451-460.
|
| 5 |
黄森林, 于立新, 邓文锋, 等. 肾移植术后人类微小病毒B19感染致纯红细胞再生障碍性贫血2例并文献复习 [J]. 器官移植, 2015, 6(4): 250-253.
|
| 6 |
邵惠训. 人类微小病毒B19感染的最新进展 [J]. 医学综述, 2011, 17(20): 3063-3064.
|
| 7 |
Waldman M, Kopp JB. Parvovirus B19 and the kidney [J]. Clin J Am Soc Nephrol, 2007, 2(1): 47-56.
|
| 8 |
Isa A, Kasprowicz V, Norbeck O, et al. Prolonged activation of virus-specific CD8＋T cells after acute B19 infection [J]. PLoS Med, 2005, 2(12): e343.
|
| 9 |
Leisi R, Di Ommaso C, Kempf C, et al. The receptor-binding domain in the VPlu region of parvovirus B19 [J]. Viruss, 2016, 8(3): 61.
|
| 10 |
Renoult E, Bachelet C, Krier-Coudert MJ, et al. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection [J]. Transplant Proc, 2006, 38(7): 2321-2323.
|
| 11 |
Kumar J, Shaver MJ, Abul-Ezz S. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion [J]. Transpl Infect Dis, 2005, 7(1): 30-33.
|
| 12 |
Tsinalis D, Dickenmann M, Brunner F, et al. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin [J]. Am J Kidney Dis, 2002, 40(3): 667-670.
|
| 13 |
Metallidis S, Papaioannou M, Bokolas G, et al. Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient [J]. Clin Nephrol, 2009, 71(2): 196-197.
|
| 14 |
Kwan TH, Tong MK, Siu YP, et al. Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman [J]. Hong Kong Med, 2005, 11(1): 45-49.
|
| 15 |
Chacko B, John GT, Balakrishnan N, et al. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy [J]. Ren Fail, 2006, 28(2): 193-195.
|
| 16 |
Heegaard ED, Brown KE. Human parvovirus B19 [J]. Clin Microbiol Rev, 2002, 15(3): 485-505.
|
| 17 |
Mouthon k, Guillevin L, Tellier Z. Intravenous immunoglobulinsinautoimmune-orparvovirusB19-mediatedpurered-cell aplasia [J]. Autoimmun Rev, 2005, 4(3): 264-269.
|
| 18 |
Crabol Y, Terrier B, rozenberg F, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature [J]. Clin Infect Dis, 2013, 56(7): 968-977.
|